HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intraperitoneal supplementation of iron alleviates dextran sodium sulfate-induced colitis by enhancing intestinal barrier function.

Abstract
Iron supplementation is necessary for the treatment of anemia, one of the most frequent complications in inflammatory bowel disease (IBD). However, oral iron supplementation leads to an exacerbation of intestinal inflammation. Gut barrier plays a key role in the pathogenesis of IBD. The aim of this study was to characterize the interrelationship between systemic iron, intestinal barrier and the development of intestinal inflammation in a dextran sulfate sodium (DSS) induced experimental colitis mice model. We found that DSS-treated mice developed severe inflammation of colon, but became much healthy when intraperitoneal injection with iron. Iron supplementation alleviated colonic and systemic inflammation by lower histological scores, restorative morphology of colonic villi, and reduced expression of pro-inflammatory cytokines. Moreover, intraperitoneal supplementation of iron enhanced intestinal barrier function by upregulating the colonic expressions of tight junction proteins, restoring intestinal immune homeostasis by regulating immune cell infiltration and T lymphocyte subsets, and increasing mucous secretion of goblet cells in the colon. High-throughput sequencing of fecal 16 S rRNA showed that iron injection significantly increased the relative abundance of Bacteroidetes, which was suppressed in the gut microbiota of DSS-induced colitis mice. These results provided evidences supporting the protective effects of systemic iron repletion by intraperitoneal injection of iron on intestinal barrier functions. The finding highlights a novel approach for the treatment of IBD with iron injection therapy.
AuthorsLi Liang, Qingqing Xiong, Jingxia Kong, Chenying Tian, Linfeng Miao, Xiaofeng Zhang, Huahua Du
JournalBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother) Vol. 144 Pg. 112253 (Dec 2021) ISSN: 1950-6007 [Electronic] France
PMID34607106 (Publication Type: Journal Article)
CopyrightCopyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Chemical References
  • Tight Junction Proteins
  • Iron-Dextran Complex
  • Dextran Sulfate
Topics
  • Animals
  • CD4-Positive T-Lymphocytes (drug effects, metabolism)
  • Colitis (chemically induced, drug therapy, metabolism, microbiology)
  • Colon (drug effects, metabolism, microbiology)
  • Dextran Sulfate
  • Dietary Supplements
  • Disease Models, Animal
  • Dysbiosis
  • Gastrointestinal Microbiome (drug effects)
  • Goblet Cells (drug effects, metabolism, microbiology)
  • Injections, Intraperitoneal
  • Intestinal Mucosa (drug effects, metabolism, microbiology)
  • Iron-Dextran Complex (administration & dosage)
  • Male
  • Mice, Inbred C57BL
  • Permeability
  • Tight Junction Proteins (metabolism)
  • Tight Junctions (drug effects, metabolism, microbiology)
  • Up-Regulation
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: